Basics of Stereochemistry, Major Techniques for Separation of Enantiomers and Overview of Chiral Separation Systems
Bezhan Chankvetadze Seminar Topics
Basics of stereochemistry, production of enantiomerically pure compounds and enantioselective analysis
Analytical and preparative-scale liquid-phase separation of enantiomers
Scientific background behind the development of Lux series of chiral columns for HPLC enantioseparations
Overview of currently available columns of Lux series for chiral HPLC separations Basics of Stereochemistry
Definition of chirality Stereoisomers (enantiomers and diastereomers) Stereogenic center Axial, planar and helical chirality Topological chirality/Chiral objects
Relevance of chirality to biological activity of chemical compounds
Chiral drugs
Comparative description of methods for preparation of enantiomerically pure chiral compounds
Analytical methods for evaluation of enantiomeric purity of chiral compounds Types of isomers
Constitutional isomers
Cis-trans/geometric isomers
Stereoisomers Diastereoisomers Meso isomers Enantiomers Definition of chiral molecules
A chiral molecule is a type of molecule that lacks an internal plane of symmetry and has a non- superimposable mirror image.
The feature that is most often the cause of chirality in molecules is the presence of an asymmetric center. Enantiomers and Diastereomers
• Stereoisomers contain the same atoms with the same connectivity but with different orientation in space. • Stereoisomers which relate to each other as the mirror images are enantiomers. • Stereisomers which do not relate to each other as the mirror images are diastereomers. • Diastereomers can be resolved by using achiral stationary phases while for separation of enantiomers a chiral stationary phase (CSP) must be used.
• The sign of optical rotation depends on the solvent used, sample concentration, wavelength, etc. and does not directly relate to the absolute stereochemical configuration of a chiral compound. Cahn-Ingold-Prelog (CIP) Nomenclature
R rectus right S sinister left
Br>Cl>F>H
CL CL
H H
Br F F Br R Fluorochlorobromoethane S
Carbon atom as a center of chirality
OH O NH2 Cl NH * C(CH3)3 HN * C2H5 H N 2 O Cl
Br
CO2CH3 CH3 NH C3H7 CH3 S C N * N * NH CH 3 O CH3 Nitrogen atom as a center of chirality
N CH3
H3C N
Troger ´s Base Sulfur atom as a center of chirality
O
O S S * O * C NH O C 2
O 2-(Benzylsulfinyl)benzamide Benzyl 2-(benzylsulfinyl)benzoic acid benzyl ester
H O O
O S N S C CH N * * 2 NH2 N H3CO
H C CH 6. 3 3 2-(Phenylsulfinyl)ethylamide O CH Omeprazole 3 Phosphor atom as a center of chirality
O Cl-C H -CH 2 2 O N P
Cl-C H 2-CH 2 N * H Cyclophosphamide
O Cl-C H -CH 2 2 O N P Trofosfamide Cl-C H -CH 2 2 * N
CH 2-CH 2-Cl
O Cl-C H -CH 2 2 O N P Iphosphamide H * N CH 2-CH 2-Cl Axial Chirality
A B CH3 H3C
OH OH
D NO H N C 2 2 2,2‘-Dimethyl-6-amino-6´- Axis of chirality 1,1´-Binaphthyl-2,2´-diol nitrobiphenyl
• Atropisomers were discovered in 1922 • a Greak for not , tropos rotation Helicenes
Hexahelicene Spirocompounds
OO H3C CH3
6,6 ´-Dimethyl-2,2 ´-spirobichromane O
O Di(naphthylcyclopentylketone)
SpiraLatin for twist or whorl Planar Chirality
• Cyclophans, Ansacompounds, Metallocens
CO H 2 Cr(CO)3
O O
CH3 CH2 CH2
CH3
(CH2)6 H3C Topological Chirality
• Catenanes, Rotaxanes, Knots • Macromolecular chirality • Chirality on the level of objects Helix Helixes in Nature
Chirality of Objects Chirality of Objects Ketotifen
Systematic ( IUPAC ) name 4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10 H-benzo[4,5]cyclohepta[1,2- b]thiophen-10-one DAD1 A, Sig=220,4 Ref=off (C1-1- BASE...2-280311\PHENOMENEX-BASE-SP-TOTAL 2011-03-28 15-09-49\032-1601.D) mAU 69 1200 90. 38 85
5.354 : 13. a 85 Are : a Lux Cellulose-1
5.964 Are 1000 n-Hex/EtOH/DEA=80/20/0.1 800 v/v/v, 1 ml/min
600
400
200
0
0 2 4 6 8 10 12 14 min Basics of Stereochemistry
Definition of chirality Stereoisomers (enantiomers and diastereomers) Stereogenic center Axial, planar and helical chirality Topological chirality (chiral objects)
Relevance of chirality to biological activity of chemical compounds
Chiral drugs
Comparative description of methods for preparation of enantiomerically pure chiral compounds
Analytical methods for evaluation of enantiomeric purity of chiral compounds Different Biological Effects of Enantiomers
• Taste • Smell • Toxicity • Pharmacology (Thalidomide) Capillary electrophoresis (CE) is very powerful technique for analytical-scale enantioseparations
O 2 N OH ** O 1 OON HO H O trans N -5´-Hydroxythalidomide [3,4] * O cis OON -5´-Hydroxythalidomide [5,6] H 5 6 5-Hydroxythalidomide [1,2] O
N * O OON 3 H 4 Thalidomide [7,8] 7 8 UV absorbance UV absorbance at 230 nm
0 5 10 15 20 25 30 time [min] Reflections of stereochemistry in the taste of compounds Basics of Stereochemistry
Definition of chirality Stereoisomers (enantiomers and diastereomers) Stereogenic center Axial, planar and helical chirality Topological chirality (chiral objects)
Relevance of chirality to biological activity of chemical compounds
Chiral drugs
Comparative description of methods for preparation of enantiomerically pure chiral compounds
Analytical methods for evaluation of enantiomeric purity of chiral compounds Chiral Drugs “Stereochemistry of the molecule must be carefully considered in all fields of pharmaceutical sciences ranging from discovery to the bedside. An understanding of the role of chirality in the properties of the molecule of interest is undoubtedly a main key to the rational process of developing as well as clinical use of chiral drugs. Keeping in mind the issue of ‘‘racemate versus single enantiomer’’ during various steps of drug discovery and development may save money and time”.
Fakhreddin Jamali, 2004. “Driven by needs of the drug industry and fuled by the ingenuity of chemists, sales of single-enantiomer chiral compounds keep accelerating”
S.C. Stinson, C&E News, May 14, 2001.
Chiral Components Sales of enantiomeric intermediates and single-enantiomer drugs are up
ENANTIOMERIC BULK INTERMEDIATES ENANTIOMERIC DRUGS $ MILLIONS 1999 2000 2005 1999 2000 2005 Anti-inflammatory/analgesics $ 150 $ 156 $ 168 $ 200 $ 223 $ 241 Antiviral 794 830 1.643 983 1.180 2.054 Cancer 892 1.073 1.297 1.783 2.146 2.593 Cardiovascular 1.133 2.281 3.269 1.889 3.802 5.449 Central nervous system 1.038 1.142 1.821 1.483 1.632 2.602
Dermatology 82 85 106 164 170 212 Gastrointestinal 251 331 649 413 567 1.082 Ophthalmic 238 284 401 340 405 573 Respiratory 576 656 914 1.151 1.511 2.287 Other 140 170 356 315 426 891 TOTAL $ 5.294 $ 7.008 $ 10.624 $8.721 $12.062 $17.984
SOURCE: Technology Catalysts International Levalbuterol (1999) S-Cetirizine (2000)
O N N N Cl NHCHO HO N O CH3 CH3 O H C N N N 3 H O OH
S-Zopiclone (2002) R,R ´-Formoterol (2003)
O H5C6 O OH N(C2H5)2 S-Oxybutinin (2003) Cl
NH2 CH3O H N
HN O O CH 3 Ticalopride
O O N
CH3O N N O
N CH3O NH 2 (S)-Doxazosin (2004)
O N N N Cl N O d HN N SEP-174559 (2004) O
CH(CH3)2
NHCH3 Cl (S)-Sibutramine metabolite e (2004) O N N
CH3 N (R)-Ondansetron
CH3
H C N NH 3 O 2
CO C H CH3O2C 2 2 5 Cl (S)-Amlodipine
CF3
O (R)-Norfluoxetine
NH2 Structure of Protease Inhibitors for the Treatment of HIV Infection
O CH3 OH OH OH N CH3 O NH2 NH NNH OH 2 N NH N N NH CH3 O O NH N O CH3 O S O NH CH O NH 3 O O O CH H3C 3 CH3SO3H CH3 Saquinavir Indinavir Amprenavir
OH CH3 CH OH OH O S 3 O NH N HO CH3 N CH3 NH NNH ONH NHN N CH3 S NH O NH CH O O NH CH 3 S CH3 O O 3 O CH3 O H3C CH3 H3CCH3
Ritonavir Lopinavir/Ritonavir Nelfinavir
L. A. Sorbera, L. Martin, J. Casta ňer, R. M. Casta ňer, Drugs of the Future, 2001, 26, 224 Basics of Stereochemistry
Definition of chirality Stereoisomers (enantiomers and diastereomers) Stereogenic center Axial, planar and helica chirality Topological chirality (chiral objects)
Relevance of chirality to biological activity of chemical compounds
Chiral drugs
Comparative description of methods for preparation of enantiomerically pure chiral compounds
Analytical methods for evaluation of enantiomeric purity of chiral compounds Strategy and need of enantioseparation techniques in chiral drug development
Drug Required Amount Cost Importance of Development enantiomer importance scale-up step feasibility
Discovery both mg-50 g minor minor
Early both 100g-10kg minor middle Development
Full active 5-100 kg middle major Development enantiomer
Production active tons major prerequisite enantiomer Preparation methods for enantiomers
Chiral Prochiral Racemates pool compounds
Kinetic Crystallization Synthesis Asymmetric synthesis resolution Scope and Limitations of Major Production Methods for Enantiomericley Pure or Enriched Molecules ------Catalysis Biocatalysis Chiral pool Resolutions HPLC ------Enantioselectivity 1-2 1 1 1-2 1 Productivity 1-2 2-3 - - - Availability, diversity 1-2 2-3 2 1 1 Substrate specificity 2 3 1 1 2 Work-up, ecology 1-2 2-3 2 2 2 Development time, effort 2 3 1 1-2 1 Application in the lab 2 3 1 1-2 1 Application in development 1-2 2 1 2 2 Small scale production 1-2 1-2 1 1-2 2 Large scale production 1 2-3 2 1-2 3 ------Rating: 1-high; 2-medium/some problems; 3-low/problematic. “For products in development, the time to develop a catalytic asymmetric process may not meet the need to get materials out rapidly for testing”
A.M. Rouhi, C & EN, June 14, 2004 Chiral Pool
OH L-(+)-Tartaric acid (s) NH2
NH2
H CH2OH
H HOH C H Cl 2 Cl (s) N N (s)
H CH2OH H
(S,S)-Ethambutol Enantioselective Synthesis
OMe H C CH OMe 3 3 H C 3 CH3 OMe N O N S (i), (ii) N ----S N N OMe H N H Esomeprazole, 94.5% ee
(iii), (iv) OMe H C 3 CH3 O N ----S N OMe N Na
Esomeprazole Sodium, 99.5% ee Preparation methods for enantiomers
Chiral Prochiral Racemates pool compounds
Kinetic Crystallization Synthesis Asymmetric synthesis resolution Methods for the Resolution of Racemates
Racemates
Preferential Kinetic Diastereomeric crystallization resolution crystallization
Chemical Enzymatic Examples of Pharmaceuticals Resolved using Diastereomeric Crystallization in the Process
Pharmaceutical Resolving agent Ampicillin D-Camphorsulphonic acid Ethambutol L-(+)-Tartaric acid Chloramphenicol D-Camphorsulphonic acid Dextropropoxyphene D-Camphorsulphonic acid Fosfomycin R-(+)-Phenethylamine Thiamphenicol D-(-)-Tartaric acid Naproxen Cinchonidine cis-Diltiazem R-(+)-Phenethylamine O O Cl Cl O Cl AlCl CH HCl N + Cl 3 3 N CH3 NH CH3 (I) (III) (IV) O CH3 (II) O CH3 EtO NH NH2 Cl O NH S CH3 N (V) O heat O S O CH3 CH3 CH O CH3 O 3 O CH3 N (VII) NH N COCl O (IX) Et3N O CH3 S CH3 CH Et3N EMD-53998 O H C 3 O CH3 NH 3 CH3 1) rac-(VIII) NH chromatographic (VI) O O O chromatographic separation separation of diastereomers of enantiomers O N O NH O NH N N N S S S
CH + CH3 3 N CH3 N N O O O CH3 (X) O CH3 O CH3 O CH CH CH O 3 O 3 O 3 (-)-EMD-53998 (EMD-57439) (+)-EMD-53998 (EMD-57033)
O (XI) NH “Despite the unrelenting pace of research in catalytic asymmetric chemistry, relatively few catalytic enantioselective processes are currently operated on a commercial scale . Until more bio- and chemocatalytic chiral routes are developed that are robust and cost-effective for large-scale production, the bulk of optically pure compounds will have to be prepared through traditional chemistry, including conventional syntheses based on chiral substances or stoichiometric chiral induction and separations, such as chromatographic resolutions .”
A.M. Rouhi, C & EN, June 14, 2004 Preparative-scale Liquid-chromatographic Separation of Enantiomers Chromatographic Separation Methods useful for Preparation of Enantiomers
• Column Chromatography
• Recycling Loop Chromatography
• Simulating-Moving Bed Chromatography
• VARICOL Schematics of SMB Unit
Solid Liquid
Zone IV
Raffinate Q raf Zone III
Feed G F Zone II
Extract Q Es Zone I
Eluent Q El
SMB is a continuous separation process Selected examples of applications of SMB-chromatography for the production of enantiomerically pure compounds.
Chiral compound CSP Capacity Consumption of the mobile phase l/g Aminoglutethimide Chiralcel OJ 7.5 g/h·kg CSP 0.740 ml 1,1'Binaphthyl-2,2'-diol Pirkle-type 3,5- 2000 g was DNBPG resolved per day Chiral drug candidate Chiralpak AD ca. 30-60 g/h·kg ca. 0.190-0.380 ml (potent partial agonist at muscarinic receptors) CGS 26 214 Chiralcel OJ 47 g/d·kg 4.561 Cycloalkanone Chiralcel OC 1082 g/d·kg 0.280 DOLE Chiralcel OF 272 g/d·kg 0.440 EMD 53 986 Polyacrylamide 319 g/d·kg 2.540 Chiralpak AD 432 g/d·kg 2.600 EMD 77 697 Chiralcel OD 451 g/d·kg 1.640 EMD 122 347 Chiralpak AD 311 g/d·kg 0.590 Formoterol Chiralcel OJ 1.2 g/h·kg 0.515 Hetrazepine Cellulose 119 g/h·kg 0.094 triacetate (CTA) Guaifenesin Chiralcel OD 10.0 g/h·kg 0.380 Oxo-oxazolidine L-Chiraspher 6.8 g/h·kg 0.900 Phenylethylalcohol Chiralcel OD 0.98 g/L 5.300 Praziquantel CTA 4.7 g/h·kg 0.056 Propranolol Chiralcel OD 3.83 g/h·kg 0.200 Sandoz-epoxide CTA 59 g/d·kg 0.800 Sandoz-epoxide Chiralcel OD 37 g/d·kg 0.500 1a, 2, 7, 7a-Tetrahydro- CTA 1.45 g/h·kg 0.400 3-methoxy-napht(2,3-6) oxirane Threonine Chirosolve L- 30 g was proline resolved Tramadol Chiralpak AD 50 g/h·kg 0.500 Wieland-Mieschler Chiralpak AD 84 g/h·kg 0.490 Ketone
Loadability of Chiral Stationary Phases
100 mg/g CSP Protein-based CSPs Vancomycin CSP 50 Cyclodextrin-based CSPs 10 Tetraamide CSPs (Kromasil 5.0 Polyacrylamide (Chiraspher) Brush-type CSPs (Pirkle) 1.0 Polysacchiride-based CSPs 0.5 0.1 Basics of Stereochemistry
Definition of chirality Stereoisomers (enantiomers and diastereomers) Stereogenic center Axial, planar and helica chirality Topological chirality (chiral objects)
Relevance of chirality to biological activity of chemical compounds
Chiral drugs
Comparative description of methods for preparation of enantiomerically pure chiral compounds
Analytical methods for evaluation of enantiomeric purity of chiral compounds “Good analytics are crucial with any project. If they are not reliable or are slower than the throughput of screening systems, they are useless”
A.M. Rouhi, C &EN, June 14. 2004. Major Techniques Available for Separation of Enantiomers
Gas Chromatography (GC)
High Performance Liquid Chromatography (HPLC)
Capillary Electrophoresis (CE)
Capillary Electrochromatography (CEC)
Supercritical Fluid Chromatography (SFC) Gas Chromatography
Advantages:
Relatively high peak efficiency
Disadvantages:
Applicable only for thermostable and volatile compounds
Limited variaty of available stationary phases
No flexibility from the viewpoint of selectivity adjustment based on the mobile phase
Not easy to be applied for preparative separations High-Performance Liquid Chromatography (HPLC) Advantages:
Applicable for thermolabile and nonvolatile compounds
Wide variety of stationary phases are available
Selectivity can be adjusted based on the mobile phase
Applicable for preparative scale separations
Disadvantage
Lower plate numbers than in oter separation techniques (GC, SFC and CE) Stationary Phases Available for HPLC Enantioseparations
Pirkle (Brush) type chiral selectors
Proteins
Cyclodextrines (Cyclofructans)
Synthetic chiral polymers (polyacrilamides, polymethacrylates)
Macrocyclic antibiotics
Cinchona alkaloids
Polysaccharides Why shall we use polysaccharide derivatives as chiral stationary phases (CSP) in liquid phase separation techniques?
• Polysaccharide based materials are rather universal CSPs
• These materials can be used with normal-, reversed- and polar organic mobile phases
• Applicable for both pressure and voltage-driven separations
• Extremely high enantioselectivity can be achieved using these CSPs for various group of analytes
• A large family of polysaccharide-based CSPs are available
• Polysaccharide-based CSPs are very useful for preparative and product scale enantioseparations Loadability of Chiral Stationary Phases
100 mg/g CSP Protein-based CSPs Vancomycin CSP 50 Cyclodextrin-based CSPs 10 Tetraamide CSPs (Kromasil 5.0 Polyacrylamide (Chiraspher) Brush-type CSPs (Pirkle) 1.0 Polysacchiride-based CSPs 0.5 0.1 Super/Sub-critical Fluid Chromatography (SFC) Advantages:
Higher plate numbers than in HPLC (but lower than in GC and CE)
Applicable for thermolabile and nonvolatile compounds
Applicable for preparative separations
Uses HPLC stationary phases
Green(er) technology
Disadvantages:
No alternative (its own) separation principle
Lower flexibility from the viewpoint of mobile phases Capillary Electrophoresis Advantages:
Alternative separation mechanism
Very high plate numbers
Various chiral selectors available
High flexibility from the viewpoint of adjustment of selectivity (and enantiomer migration order
Miniaturized technique
Disadvantages:
May require special skills on order to achieve required reproducibility/repeatability
Not applicable for gaseous molecules
Not applicable for preparative separations Separation Technology
Chiral Selector
Carrier
Mobile Phase Major Liquid-phase Instrumental Techniques Available for Separation of Enantiomers
High Performance Liquid Chromatography (HPLC)
Supercritical Fluid Chromatography (SFC)
Capillary Electrophoresis (CE)
Capillary Electrochromatography (CEC)
(Microfabricated devices) Buffer reservoirs CZE
Flow profiles in chromatography and CE
Parabolic flow Chromatography
Plug-like flow Electrodriven techniques
Narrow peaks Capillary electrophoresis (CE) is very powerful technique for analytical-scale enantioseparations
O 2 N OH ** O 1 OON HO H O trans N -5´-Hydroxythalidomide [3,4] * O cis OON -5´-Hydroxythalidomide [5,6] H 5 6 5-Hydroxythalidomide [1,2] O
N * O OON 3 H 4 Thalidomide [7,8] 7 8 UV absorbance UV absorbance at 230 nm
0 5 10 15 20 25 30 time [min] Enantioseparation of meptazinol with βββ-CD column in HPLC and simultaneous enantioseparation of meptazinol and metabolites in CE using βββ-CD as a chiral selector -4
Meptazinol 10 3-Hydroxyehtyl- OH 40 (-) meptazinol (+)
CH CH 30 N-Desmethyl- 2 3 Absorbance meptazinol Meptazinol N CH 3 20 (-)(+)
10
0 20 60 100 10 Time, (min) Time, (min) Capillary electrophoresis is very powerful technique not only for analytical scale enantioseparations but also for investigation of fine mechanisms of enantioselective intermolecular interactions. Advantages of CE for Separation of Enantiomers
CE allows very fast screening of selector-select and interactions in order to prevail the most promising chiral selector. There is no other instrumental separation or non-separation technique that may compete with CE in this respect.
The high peak efficiency in CE permits to observe (enantio)selective features in selector-selectand interactions which are invisible by other (separation) techniques.
A small thermodynamic selectivity of recognition can be transformed into a high separation factor in CE.
CE is more flexible than chromatographic techniques in order to adjust the (enantio)separation factor
Combination of chiral selectors is much easier in CE than in HPLC. Techiques Available for Mechanistic Studies Related to Chiral CE: 1. X- ray crystallography (Provides information about most likely stoichiometry and structure of selector-selectand complex but in the solid state)
2. NMR spectroscopy (Provides information about the stoichiometry, binding constants and structure of selector-selectand associates in solution but is not suitable for mixed complexes)
3. Mass Spectrometry (Provides information about the stoichiometry and the binding constants of selector-selectand complexes and is also suitable for mixed complexes)
4. Molecular Modeling/Mechanics Calculations (May allow to calculate major forces involved in intermolecular interactions and in chiral recognition) X-Ray Structure of the Complexes of brompheniramine maleate with βββ-CD (a) and heptakis-(2,3,6-tri-O-methyl )-βββ-CD (b)
10 -3 -3 30 10 TM-β-CD S β-CD S 20 20 R 15 R
10 10 5
0 0 12 13 14 15 16 14 18 22 26 30 Time (min) Time (min) Affinity of Aminoglutethimide Enantiomers Towards Native Cyclodextrins (ααα, βββ, γγγ)
α β γ H1-NMR spectra of (±)-aminoglutethamide complexes with ααα-, βββ-, and γγγ-CDs
a)
b)
c) βββ-CD/ aminoglutethimide Complex
meta
ortho O6 C6
O5 C5 H5 C1 C4
C2 H3 C3
O2 O3
βββ-Cyclodextrin/aminoglutethimide Complex γγγ- CD/aminoglutethimide Complex
ortho meta
meta ortho O6 C6
O5 C5 H5 C1 C4 H3 C2 C3
O2 O3
γγγ-Cyclodextrin/aminoglutethimide Complex CE Enantioseparation and the Structure of Complexes Between aminoglutethimide and βββ- and γγγ-cyclodextrins
Aminoglutethimide
O6 O6 C6 C6
O5 C5 O5 C5 H5 H5 C1 C4 C1 C4 γγγ−γ−−−CD H3 C2 βββ-CD H3 C3 C2 C3
O2 O3 O2 O3 1D-ROESY Spectrum of (+/-)- clenbuterol Complex with βββ-CD
βββ-CD O6 H-1 C(CH 3)3 H-6 C6 H-3 H-4 O5 C5 Har H-5 H-2 H5 CH 2 C1 C4
C2 H3 C3
O2 O3 C(CH 3)3
CH 2
CH 2
Har
ppm 7.1 4.6 3.3 2.9 1.2 1D-ROESY spectrum of (+/-)- clenbuterol complex with HDA-βββ-CD HDA-βββ-CD H-1 H-5H-4 COCH 3 O6 C6 H H-3 C(CH ) ar H-2 3 3 H-6 H-6´ O5 C5 H5 CH 2 C1 C4 H3 C2 C3
O2 O3 C(CH 3)3 C7 C8
C(CH 3)3
CH 2
Har
ppm 7.1 3.9 3.0 1.9 1.2 1D-ROESY spectrum of (+/-)-clenbuterol complex with HDA-βββ-CD
H-5/H-4 COCH 3 H H-3 H-1 ar H-2 H-6 H-6´ C(CH 3)3 CH 2
HDA-βββ-CD O6 C6 COCH 3 O5 C5 H5 C1 C4 (H-5)+(H-4) H3 C2 C3
H-6´ O2 O3 C7 C8 H-6
H-2
H-1
H-3 Enantioseparation of clenbuterol with βββ-CD and heptakis-(2,3-diacetyl-βββ-CD) and structure of intermolecular complexes in solution HDA-βββ-CD βββ-CD O6 O6 C6 C6
O5 C5 O5 C5 H5 H5 C1 C4 C1 C4 H3 H3 C2 C3 C2 C3
O2 O3 O2 O3 C7 C8
-3 10 10 -3 30 S S 20
20 R R
10 10
0 0
12 14 16 14 22 30 Time (min) Time (min) Clenbuterol MM+ Optimized Structure of clenbuterol/ βββ-CD Complex MM+ Optimized Structure of clenbuterol/ βββ-CD Complex MM+ optimized structure of clenbuterol/HDA-βββ-CD complex MM+ optimized structure of clenbuterol/HDA-βββ-CD c omplex 15 mM HDMS-β-CD 25 mM HDAS-β-CD 18 12 Normal Normal polarity 16 10 d) non-aqueous a) aqueous S polarity 14 8 S
12 6 10 4 R
R mAU mAU 8 2 6 0 4
-2 2
0 -4 6 7 8 9 10 11 12 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Time (min) Time (min) H1 H1
H2 H1 H3 H3
H4 H2 H5 H5 H3 H3
H4
H6 H5 H5
H6 Electrophoresis, 2010, 31, 1667-1674 J. Sep. Sci., 2010, 33, 1617-1624 Correlations Between Structure and Binding (Nonaqueous medium)
R-Propranolol/HDAS-βββ-CD S-Propranolol/HDAS-βββ-CD 1 2
1 0
8 S 6 R
4 mAU
2
0
-2
-4 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Tim e (m in) Major Liquid-phase Instrumental Techniques Available for Separation of Enantiomers
High Performance Liquid Chromatography (HPLC)
Supercritical Fluid Chromatography (SFC)
Capillary Electrophoresis (CE)
Capillary Electrochromatography (CEC)
(Microfabricated devices) Capillary Electrochromatography
• o-CEC (open tubular capillary electrochromatography)
• p-CEC (packed capillary electrochromatography)
• rod-CEC (monolithic capillary electrochromatography) p-CEC
•Combines selectivity of LC and efficiency of CE • Applicable for neutral compounds Pore structure and particle size of packing material Scanning electron microscopy (SEM) Monolithic columns for CEC
• Inorganic (silica-based) monoliths
• Organic Monoliths
• Hybrid Organic-inorganic monoliths 100 µm ID monolithic silica capillary before and after modification with polysaccharide derivative CLC vs. CEC
(+)-piprozolin Capillary LC (-)-piprozolin Capillary LC CEC CEC 40 40 HETP HETP (µm) HETP HETP (µm)
20 20
0 0 0 1 2 0 1 2 Linear flow velocity (mm/sec ) Linear flow velocity (mm/sec)
2.5mM ammonium acetate. in MeOH Native silica- 2000 Å, 5µm , 5% CDCPC
♦At the optimal flow rate peak efficiency in CEC is at least two times higher compared to capillary LC
♦ CEC tolerates high linear flow velocities much better than capillary LC Does CEC offer higher peak efficiency compared to CLC under identical conditions?
O
S b) CEC: -5 kV a) Capillary LC: 12 bar inlet vial NH 2 C N1: 160061/m O N2: 154852/m R : 1.65 2-Benzylsulfinylbenzamide S CLC CEC mAU mAU
200 80
100 40
0 5 10 15 20 0 5 10 15 20 time (min) time (min) CLC vs. CEC
(+)-piprozolin Capillary LC (-)-piprozolin Capillary LC CEC CEC 40 40 HETP HETP (µm) HETP HETP (µm)
20 20
0 0 0 1 2 0 1 2 Linear flow velocity (mm/sec ) Linear flow velocity (mm/sec)
2.5mM ammonium acetate. in MeOH Native silica- 2000 Å, 5µm, 5% CDCPC
♦At the optimal flow rate peak efficiency in CEC is at least two times higher compared to capillary LC
♦ CEC tolerates high linear flow velocities much better than capillary LC Fast Enantioseparation of ( ±±±)-piprozolin in CEC
(-)-Piprozolin
S N OC2H5 (+)-Piprozolin * N O O
CH3
-1 N1=168 750 m -1 Thiourea N2=117 400 m
0.5 1 Time (min)
5% CDCPC, CSP : Aminopropylsilanized silica gel (2000 Å, 5 µµµm), 8.5 cm packed bed. Buffer: 10 mM ammonium acetate; Applied voltage: 25 kV Enantioseparation of thalidomide and its metabolites in CLC and CEC CLC (13 bar) CEC (20 kV) Absorbance 5-OH 5-OH 5-OH Absorbance 5-OH Thalidomide Thalidomide 5'-OH Thalidomide 5'-OH + 5'-OH Thalidomide 5{'-OH
20 30 40 50 Time (min) 10 25 40 Time (min)
Separation conditions: 25 % (OD+AD), native silica 2000 Å, 5 µm. Buffer: 10 mM ammonium acetate in (MeOH+EtOH (55/45).